Medication Profile – ISMP High Alert Medications

As always, we want to be a reliable industry source for the most recent and relevant branding and regulatory topics. The Institute for Safe Medication Practices (ISMP) updated the list of High Alert Medications in Long-Term Care (LTC) settings in May 2021. What do you need to know off the bat?

Firstly, the list has two sections:

  1. General medication classes/categories (e.g., anti-Parkinson’s drugs, antithrombotic drugs, opioids, GABA analogues, sulfonylurea hypoglycemic drugs)
  2. Specific medications (e.g., digoxin, sacubitril/valsartan [Entresto®], methotrexate, concentrated morphine oral solution).

Each list is intended to help facilitate which medication may require special protections to reduce the risk of error, like standardizing medication use processes, auxiliary labels and automated alerts, limited access, employing redundancies, and to align with other resources for medication use in elderly populations, such as the Beers Criteria and the STOPP and START Criteria.

For more information, please visit: https://www.ismp.org/recommendations/high-alert-medications-long-term-care-list or reach out to our regulatory experts.